UBS Group AG - NEUROSENSE THERAPEUTICS LTD ownership

Back to all holdings Add to watchlist

NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240116. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
UBS Group AG ownership history of NEUROSENSE THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$422
+229.7%
3,802
+376.4%
0.00%–
Q4 2022$128–798
-59.2%
0.00%–
Q3 2022$0
-100.0%
1,958
-56.4%
0.00%–
Q4 2021$4,000–4,491–0.00%–
 Download
Other shareholders
NEUROSENSE THERAPEUTICS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Warberg Asset Management LLC 79,668$14,3800.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CLEAR STREET LLC 56,796$90.00%
Hudson Bay Capital Management LP 150,000$30,0000.00%
UBS Group AG 798$1280.00%
View complete list of NEUROSENSE THERAPEUTICS LTD shareholders